Carl Wild
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.2MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 26, 2026 | NIH | SBIR Phase II IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents | $965K | DFH Pharma, Inc |
| Sep 26, 2025 | NIH | SBIR Phase II IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents | $987K | DFH Pharma, Inc |
| Jun 18, 2021 | NIH | STTR Phase II Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $424K | DFH Pharma, Inc |
| Jul 8, 2020 | NIH | STTR Phase II Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $943K | DFH Pharma, Inc with OAK CREST INSTITUTE OF SCIENCE |
| Jul 7, 2020 | NIH | STTR Phase II Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $519K | DFH Pharma, Inc |
| Sep 1, 2018 | NIH | STTR Phase I Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $171K | DFH Pharma, Inc with SOUTH DAKOTA STATE UNIVERSITY |
| Aug 31, 2018 | NIH | STTR Phase I Preclinical Development of 2nd Generation HIV Maturation Inhibitors | $171K | DFH Pharma, Inc |
Peer ranks
Federal funding#363
Awards as PI#250
Patents#273
Companies
- DFH Pharma, IncLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.